Quantifying Tip60 (Kat5) stratifies breast cancer

Breast cancer is stratified into four distinct clinical subtypes, using three key biomarkers (Her2/Neu gene status, Estrogen and Progesterone receptor status). However, each subtype is a heterogeneous group, displaying significant variation in survival rates and treatment response. New biomarkers ar...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, A., Casey, M. C., Shalaby, A., Kalinina, O., Curran, C., Webber, M., Callagy, G., Holian, E., Bourke, E., Kerin, M. J., Brown, J. A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405843/
https://www.ncbi.nlm.nih.gov/pubmed/30846725
http://dx.doi.org/10.1038/s41598-019-40221-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405843/
https://www.ncbi.nlm.nih.gov/pubmed/30846725
http://dx.doi.org/10.1038/s41598-019-40221-5

Ejemplares similares